IssueHealth Canada is advising Canadians that Apotex Inc. is voluntarily recalling one lot (lot 6G07) of its Apo-Nitroglycerin sublingual (under the tongue) spray (0.4 mg/metered dose) as the spray ...
GoNitro Espero announced that the Food and Drug Administration (FDA) has approved GoNitro (nitroglycerin) sublingual powder for acute relief of an attack or prophylaxis of angina pectoris due to ...
OTTAWA Health Canada is advising consumers that Mylan Pharmaceuticals ULC has begun a voluntary recall of certain lots of a nitroglycerin heart medication from retailers. Some lots of the product, ...
GoNitro Espero announced the launch of GoNitro (nitroglycerin) sublingual powder for acute relief of an attack or prophylaxis of angina pectoris due to coronary artery disease. Espero announced the ...
JACKSONVILLE, Fla.--(BUSINESS WIRE)--Espero Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved ...
JACKSONVILLE, Fla.--(BUSINESS WIRE)--Espero Pharmaceuticals Inc., a privately held specialty pharmaceutical company, today announced the commercial availability of GONITRO™ (nitroglycerin) sublingual ...
What to do: Speak with your healthcare professional about how best to manage any impact of this shortage. Obtain only the amount you need. Keep expired product and check the table below to determine ...
ALLEGAN (WWJ) --Perrigo Co. (NYSE: PRGO) announced that it has received final approval for its abbreviated new drug application for nitroglycerin lingual spray, 400 mcg/spray, the generic equivalent ...
Accordingly to New York Times journalist Natasha Singer, approximately four million prescriptions for nitroglycerin were written in the US in 2009 [1]. The American HeartAssociation statistics show ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback